scholarly journals Response to Comment on Sarkar et al. Exenatide Treatment for 6 Months Improves Insulin Sensitivity in Adults With Type 1 Diabetes. Diabetes Care 2014;37:666–670

Diabetes Care ◽  
2014 ◽  
Vol 37 (10) ◽  
pp. e219-e220
Author(s):  
Gayatri Sarkar ◽  
May Alattar ◽  
Rebecca J. Brown ◽  
Michael J. Quon ◽  
David M. Harlan ◽  
...  
Keyword(s):  
Type 1 Diabetes ◽  
Insulin Sensitivity ◽  
Diabetes Care

scholarly journals Comment on Sarkar et al. Exenatide Treatment for 6 Months Improves Insulin Sensitivity in Adults With Type 1 Diabetes. Diabetes Care 2014;37:666–670

Diabetes Care ◽  
2014 ◽  
Vol 37 (10) ◽  
pp. e218-e218 ◽  
Author(s):  
Ajay Chaudhuri ◽  
Nitesh Kuhadiya ◽  
Husam Ghanim ◽  
Paresh Dandona
Keyword(s):  
Type 1 Diabetes ◽  
Insulin Sensitivity ◽  
Diabetes Care

1054-P: Insulin Sensitivity from Sensor and Pump Data in Youths with Type 1 Diabetes: Hybrid Closed-Loop Validation

Diabetes ◽  
2019 ◽  
Vol 68 (Supplement 1) ◽  
pp. 1054-P
Author(s):  
MICHELE SCHIAVON ◽  
ALFONSO GALDERISI ◽  
KRISTEN A. KRAEMER ◽  
CLAUDIO COBELLI ◽  
CHIARA DALLA MAN ◽  
...  
Keyword(s):  
Type 1 Diabetes ◽  
Insulin Sensitivity ◽  
Closed Loop

scholarly journals The potential effect of metabolic alkalosis on insulin sensitivity in an adolescent with new‐onset type 1 diabetes

2021 ◽  
Vol 9 (5) ◽  
Author(s):  
William E. Novotny ◽  
Irma Fiordalisi ◽  
Cynthia P. Keel ◽  
Glenn D. Harris
Keyword(s):  
Type 1 Diabetes ◽  
Insulin Sensitivity ◽  
Metabolic Alkalosis ◽  
Potential Effect ◽  
Onset Type ◽  
New Onset

Sex hormones and insulin sensitivity in adolescent girls with type 1 diabetes

2020 ◽  
Vol 46 (1) ◽  
pp. 75-77
Author(s):  
Beata Mianowska ◽  
Iwona Pietrzak ◽  
Małgorzata Perenc ◽  
Anna Baranowska-Jaźwiecka ◽  
Wojciech Fendler ◽  
...  
Keyword(s):  
Type 1 Diabetes ◽  
Insulin Sensitivity ◽  
Sex Hormones ◽  
Adolescent Girls

scholarly journals Serum uric acid and insulin sensitivity in adolescents and adults with and without type 1 diabetes

2014 ◽  
Vol 28 (3) ◽  
pp. 298-304 ◽  
Author(s):  
Petter Bjornstad ◽  
Janet K. Snell-Bergeon ◽  
Kimberly McFann ◽  
R. Paul Wadwa ◽  
Marian Rewers ◽  
...  
Keyword(s):  
Type 1 Diabetes ◽  
Uric Acid ◽  
Insulin Sensitivity ◽  
Serum Uric Acid ◽  
Adolescents And Adults

Insulin resistance and risk of vascular events, interventions and mortality in type 1 diabetes

2021 ◽  
Author(s):  
Marga A.g. Helmink ◽  
Marieke de Vries ◽  
Frank L.j. Visseren ◽  
Wendela L. de Ranitz ◽  
Harold W. de Valk ◽  
...  
Keyword(s):  
Insulin Resistance ◽  
Cardiovascular Disease ◽  
Type 1 Diabetes ◽  
Insulin Sensitivity ◽  
Lower Risk ◽  
Cardiovascular Events ◽  
Additional Risk Factor ◽  
Vascular Events ◽  
All Cause Mortality

Objective: To identify determinants associated with insulin resistance and to assess the association between insulin resistance and cardiovascular events, vascular interventions and mortality in people with type 1 diabetes at high risk of cardiovascular disease . Design: Prospective cohort study. Methods: 195 people with type 1 diabetes from the Secondary Manifestations of ARTerial disease (SMART) cohort were included. Insulin resistance was quantified by the estimated glucose disposal rate (eGDR) with higher eGDR levels indicating higher insulin sensitivity (i.e. lower eGDR levels indicating higher insulin resistance). Linear regression models were used to evaluate determinants associated with eGDR. The effect of eGDR on cardiovascular events, cardiovascular events or vascular interventions (combined endpoint) and on all-cause mortality was analysed using Cox proportional hazards models adjusted for confounders. Results: In 195 individuals (median follow-up 12.9 years, IQR 6.7-17.0), a total of 25 cardiovascular events, 26 vascular interventions and 27 deaths were observed. High eGDR as a marker for preserved insulin sensitivity was independently associated with a lower risk of cardiovascular events (HR 0.75; 95%CI 0.61-0.91), a lower risk of cardiovascular events and vascular interventions (HR 0.74; 95%CI 0.63-0.87), and a lower risk of all-cause mortality (HR 0.81; 95%CI 0.67-0.98). Conclusions: Insulin resistance as measured by eGDR is an additional risk factor for cardiovascular disease in individuals with type 1 diabetes. Modification of insulin resistance by lifestyle interventions or pharmacological treatment could be a viable therapeutic target to lower the risk of cardiovascular disease.

scholarly journals Diabetes Care, Glycemic Control, Complications, and Concomitant Autoimmune Diseases in Children with Type 1 Diabetes in Turkey: A Multicenter Study

2013 ◽  
Vol 5 (1) ◽  
pp. 20-26 ◽  
Author(s):  
Gökşen Şimşek Damla ◽  
Aycan Zehra ◽  
Özen Samim ◽  
Çetinkaya Semra ◽  
Kara Cengiz ◽  
...  
Keyword(s):  
Type 1 Diabetes ◽  
Glycemic Control ◽  
Autoimmune Diseases ◽  
Multicenter Study ◽  
Diabetes Care
Sign in / Sign up

Export Citation Format

Share Document